Peptides & Research
High-Risk Payment Processing Solutions
Free consultation. No obligation.
All lawful industries are welcome to apply. High-risk and hard-to-place businesses are our specialty.
YOUR BUSINESS, UNDERSTOOD
Cybin Enterprises specializes in payment processing for the Research Chemicals industry. We connect Peptides & Research businesses with specialized high-risk merchant account providers for options reviewed against the actual business model. We help prepare the application and compare written fees, reserves, limits, and funding. Approval and terms are determined by the processor or acquiring bank.
Review product classification, intended use, marketing, and applicable requirements with qualified counsel. Processing approval does not establish legal clearance for a substance or claim.
Industry reference: FDA Bulk Drug Substances for Compounding
BEFORE YOU APPLY
DIRECT UNDERWRITING ANSWER
Potentially. The review turns on the exact catalog, intended use, labeling and marketing, customer controls, jurisdictions, fulfillment, and processing history. A research-use-only label does not establish eligibility by itself; the underwriter needs the website and operating evidence to match the stated business model.
No. A processor reviews the complete catalog, marketing and operating model. FDA's RUO guidance is specific to certain in-vitro diagnostic products, so a merchant should not treat the phrase as a universal regulatory safe harbor.
Show recent statements, exact monthly and peak volume, ticket sizes, inventory and fulfillment capacity, refund and dispute performance, customer controls, and the capacity requested. Cybin prioritizes established businesses processing at least $500,000 per month, with $1 million or more per month the strongest fit for enterprise review.
This is application-preparation guidance, not a promise of approval or legal advice. The processor or acquiring bank decides eligibility, pricing, reserves, limits, funding, and activation after reviewing the complete business.
Reviewed September 22, 2026 by Cybin Enterprises editorial team. Official references: FDA: Research Use Only and Investigational Use Only IVD guidance; FTC: Health Products Compliance Guidance
Use these questions when discussing your business with a prospective processor. Written approval and account terms should match what you actually sell and how you bill.
Prepare the actual business model, processing history, and requested documents. Confirm transaction coding, applicable monitoring rules, account limits, and written terms with the provider.
Describe what the research chemicals business sells, who it serves, how it bills, and when it delivers. Provide the requested evidence and identify unresolved questions; the processor or acquiring bank controls approval and account terms.
Ask the acquirer to confirm transaction coding and the current rules for the actual research chemicals business. A category label or a suggested code does not establish acceptance.
Use your own research chemicals transaction and dispute records to identify causes, improve the customer experience, and prepare relevant evidence. Check monitoring definitions and account limits with the acquirer rather than relying on one universal percentage.
Each proposed method and provider must accept the actual business. Compare eligibility, fees, funding, controls, and operational responsibilities before changing the research chemicals payment flow.
Sources: Visa VAMP overview · Mastercard merchant security rules
Providers can review or restrict accounts when the business falls outside their policy or approved terms.
Dispute exposure depends on the transactions, fulfillment, billing, and customer experience.
Provider acceptance varies by product, business model, markets, and processing history.
Identify the requirements relevant to the business and the documentation the provider requests.
If Stripe, PayPal, or Square just shut down your research chemicals account, start with these practical documentation and continuity steps.
Review the provider notice and account agreement before acting. A hold can last for months and may be reduced by refunds, chargebacks, fees, reserves, or legal obligations. Preserve every notice and keep responding to valid information requests.
Account reviews can follow dispute activity, volume changes, policy questions, or documentation requests. Follow the deadline in the provider notice and submit accurate, complete records through the provider's official channel.
Follow the provider's formal appeal process and preserve the agreement, notices, and responses. Depending on the account type and jurisdiction, an appropriate regulator or attorney may also be able to clarify available options.
Prepare for processor review by organizing accurate business records, processing history, product details, policies, and risk controls. Review timing and the final decision remain with the processor or acquiring bank.
Once processing is restored, review whether approved backup payment rails fit your business. Any additional processor or payment method needs its own underwriting, integration, and compliance review.
We match you with processors who understand your industry.
Review account terms, funding conditions, and contingency options. Processors may change or close accounts.
We help compare processor quotes, fees, reserve terms, and contract conditions for your business.
Our team understands high-risk and provides ongoing support.
Compare how a case-specific placement review differs from general-purpose payment platform eligibility.
Scroll sideways to compare all columns on smaller screens.
| Feature | Cybin Enterprises | Stripe / PayPal / Square |
|---|---|---|
| Eligibility Review | Case-specific review for Research Chemicals | Eligibility depends on each platform's policies |
| Approval Process | Support preparing a processor-ready file | Automated or manual review; timing varies |
| Pricing | Written processor terms after underwriting | Published pricing may not reflect eligibility or final terms |
| Reserves | If required, defined in written processor terms | Requirements vary by provider and risk review |
| Account Review | Specialist placement guidance | Monitoring and review practices vary |
| Support | Cybin application guidance | Support model varies by provider |
| Dispute Controls | Controls matched to processor requirements | Thresholds and tools vary by provider |
| Contract Terms | Reviewed before placement | Terms vary by provider |
| Settlement | Defined in the processor agreement | Provider policies and hold terms vary |
| Prior Termination or MATCH | Reviewed case by case | Eligibility varies by provider |
High-Risk Specialists
Competitive Rates
File Review
Multiple Processors
Chargeback Management
Application Support
Our specialists understand the Peptides & Research industry. Get matched with the right processor today.
All lawful industries are welcome to apply. High-risk and hard-to-place businesses are our specialty.
Case-Specific Review · No Commitment
Processors may treat research chemicals businesses as higher risk depending on the product mix, fulfillment model, dispute exposure, regulatory requirements, and jurisdictions served. Self-serve providers may restrict or review businesses whose products or risk profile fall outside their policies.
Common requests may include business formation documents, government-issued ID, bank statements, processing history, industry-specific licenses, and compliance materials. Exact requirements vary by processor, business model, and risk profile.
Cybin helps prepare and route a complete, processor-ready research chemicals file. Actual timing varies with the business model, documentation, processing history, volume, and processor review. The processor or acquiring bank controls the final decision and timing.
Rates, transaction fees, reserves, settlement timing, and other terms are set by the processor after underwriting. Cybin helps applicants compare the written terms for eligible options before they choose a processor.
A prior termination, elevated chargeback history, or MATCH list record does not by itself determine eligibility. Available options are reviewed case by case, and the processor or acquiring bank makes the final decision.
Domestic or offshore options may be considered depending on the industry, jurisdiction, product mix, business model, and processor policy. Availability is case-specific and subject to underwriting.
How research-use-only peptide and specialty-compound merchants get placed with processors that underwrite the category.
Read the guideDeclined or shut down by Stripe? Cybin helps you find a suitable processor and prepare your application.
Read the guide